Fingolimod phosphate promotes the neuroprotective effects of microglia

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 13-18

  Noda, Hiromi ^a   Takeuchi, Hideyuki ^a   Mizuno, Tetsuya ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Fingolimod; Microglia; Neuroprotection; Neurotrophic factor; Pro inflammatory cytokine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; FINGOLIMOD; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; DISEASE ASSOCIATION; DOWN REGULATION; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOID ORGAN; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROPROTECTIVE AGENTS; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SPHINGOSINE;

EID: 84875367110     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.12.005     Document Type: Article

References (47)

1. Almolda B., Gonzalez B., Castellano B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front. Biosci. 2011, 16:1157-1171.
2. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
3. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
4. Brinkmann V. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 2009, 158:1173-1182.
5. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P., Foster C.A., Zollinger M., Lynch K.R. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002, 277:21453-21457.
6. Chi H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol. Sci. 2011, 32:16-24.
7. Chun J., Hartung H.P. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol. 2010, 33:91-101.
8. Cohen J.A., Barkhof F., Comi G., Hartung H.P., Khatri B.O., Montalban X., Pelletier J., Capra R., Gallo P., Izquierdo G., Tiel-Wilck K., de Vera A., Jin J., Stites T., Wu S., Aradhye S., Kappos L. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 2010, 362:402-415.
9. Cohen J.A., Chun J. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann. Neurol. 2011, 69:759-777.
10. Durafourt B.A., Lambert C., Johnson T.A., Blain M., Bar-Or A., Antel J.P. Differential responses of human microglia and blood-derived myeloid cells to FTY720. J. Neuroimmunol. 2011, 230:10-16.
11. Foster C.A., Howard L.M., Schweitzer A., Persohn E., Hiestand P.C., Balatoni B., Reuschel R., Beerli C., Schwartz M., Billich A. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J. Pharmacol. Exp. Ther. 2007, 323:469-475.
12. Furumai R., Ito A., Ogawa K., Maeda S., Saito A., Nishino N., Horinouchi S., Yoshida M. Histone deacetylase inhibitors block nuclear factor-kappaB-dependent transcription by interfering with RNA polymerase II recruitment. Cancer Sci. 2011, 102:1081-1087.
13. Gao F., Liu Y., Li X., Wang Y., Wei D., Jiang W. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model. Pharmacol. Biochem. Behav. 2012, 103:187-196.
14. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
15. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
16. Guerrero M., Urbano M., Velaparthi S., Zhao J., Schaeffer M.T., Brown S., Rosen H., Roberts E. Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists. Bioorg. Med. Chem. Lett. 2011, 21:3632-3636.
17. Jimenez S., Baglietto-Vargas D., Caballero C., Moreno-Gonzalez I., Torres M., Sanchez-Varo R., Ruano D., Vizuete M., Gutierrez A., Vitorica J. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 2008, 28:11650-11661.
18. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
19. Lee C.W., Choi J.W., Chun J. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. Arch. Pharm. Res. 2010, 33:1567-1574.
20. Liang J., Takeuchi H., Jin S., Noda M., Li H., Doi Y., Kawanokuchi J., Sonobe Y., Mizuno T., Suzumura A. Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway. Brain Res. 2010, 1322:8-23.
21. Maceyka M., Harikumar K.B., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22:50-60.
22. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., Thornton R., Shei G.J., Card D., Keohane C., Rosenbach M., Hale J., Lynch C.L., Rupprecht K., Parsons W., Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
23. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
24. Mizuno T., Kurotani T., Komatsu Y., Kawanokuchi J., Kato H., Mitsuma N., Suzumura A. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 2004, 46:404-411.
25. Nakanishi H., Wu Z. Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res. 2009, 201:1-7.
26. Newton K., Dixit V.M. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 2012, 4.
27. Norimatsu Y., Ohmori T., Kimura A., Madoiwa S., Mimuro J., Seichi A., Yatomi Y., Hoshino Y., Sakata Y. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am. J. Pathol. 2012, 180:1625-1635.
28. Sanna M.G., Wang S.K., Gonzalez-Cabrera P.J., Don A., Marsolais D., Matheu M.P., Wei S.H., Parker I., Jo E., Cheng W.C., Cahalan M.D., Wong C.H., Rosen H. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol. 2006, 2:434-441.
29. Sawada M. Neuroprotective and toxic changes in microglia in neurodegenerative disease. Parkinsonism Relat. Disord. 2009, 15(Suppl. 1):S39-S41.
30. Seabrook T.J., Jiang L., Maier M., Lemere C.A. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 2006, 53:776-782.
31. Sriram S. Role of glial cells in innate immunity and their role in CNS demyelination. J. Neuroimmunol. 2011, 239:13-20.
32. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 2004, 24:2182-2190.
33. Suzumura A., Mezitis S.G., Gonatas N.K., Silberberg D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol. 1987, 15:263-278.
34. Takeuchi H. Neurotoxicity by microglia: mechanisms and potential therapeutic strategy. Clin. Exp. Neuroimmunol. 2010, 1:12-21.
35. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
36. Takeuchi H., Kobayashi Y., Ishigaki S., Doyu M., Sobue G. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277:50966-50972.
37. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., Suzumura A. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 2005, 280:10444-10454.
38. Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T., Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol. Dis. 2006, 22:33-39.
39. Town T., Nikolic V., Tan J. The microglial "activation" continuum: from innate to adaptive responses. J. Neuroinflammation 2005, 2:24.
40. Wei Y., Yemisci M., Kim H.H., Yung L.M., Shin H.K., Hwang S.K., Guo S., Qin T., Alsharif N., Brinkmann V., Liao J.K., Lo E.H., Waeber C. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 2011, 69:119-129.
41. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22:1763-1771.
42. Wu X., Chen P.S., Dallas S., Wilson B., Block M.L., Wang C.C., Kinyamu H., Lu N., Gao X., Leng Y., Chuang D.M., Zhang W., Lu R.B., Hong J.S. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int. J. Neuropsychopharmacol. 2008, 11:1123-1134.
43. Wu Z., Tokuda Y., Zhang X.W., Nakanishi H. Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol. Dis. 2008, 32:543-551.
44. Wynne A.M., Henry C.J., Huang Y., Cleland A., Godbout J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 2010, 24:1190-1201.
45. Yoshino T., Tabunoki H., Sugiyama S., Ishii K., Kim S.U., Satoh J. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2. Cell. Mol. Neurobiol. 2011, 31:1009-1020.
46. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15769-15774.
47. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.